Jun 13, 2022 8:00am EDT Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
Feb 17, 2022 8:00am EST Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
Jan 10, 2022 9:00am EST Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
Jan 04, 2022 8:30am EST Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
